The GPRIN2 Polyclonal Antibody (PACO23434) is designed for research involving GPRIN2, a protein involved in intracellular signaling pathways and neuronal function. The antibody, raised in rabbits, is highly specific for human samples and has been validated for use in various applications, including Western blotting.GPRIN2 is known to play a role in synaptic plasticity and neurotransmitter release, making it a key target for studies in neuroscience and neurodegenerative diseases. Its function in regulating cellular signaling pathways suggests its potential involvement in cancer progression and metastasis, making it a promising candidate for further research in oncology.
By utilizing the GPRIN2 Polyclonal Antibody, researchers can investigate the role of GPRIN2 in various cellular processes and disease contexts, providing valuable insights into potential therapeutic strategies for neurological disorders and cancer. Understanding the function of GPRIN2 is essential for advancing our knowledge of neuronal communication and disease pathology, ultimately leading to the development of targeted treatments and interventions.
